St. Jude Medical COO Michael T. Rousseau Unloads 4,644 Shares (STJ)
St. Jude Medical (NYSE:STJ) COO Michael T. Rousseau unloaded 4,644 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $59.76, for a total value of $277,525.44. Following the completion of the transaction, the chief operating officer now directly owns 18,711 shares of the company’s stock, valued at approximately $1,118,169. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on STJ. Analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note to investors on Thursday, January 30th. They now have a $64.00 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of St. Jude Medical from $40.00 to $51.00 in a research note to investors on Thursday, January 23rd. They now have a “sell” rating on the stock. Finally, analysts at Wedbush raised their price target on shares of St. Jude Medical from $62.00 to $73.00 in a research note to investors on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have given a buy rating to the company. St. Jude Medical presently has a consensus rating of “Buy” and an average target price of $57.22.
Shares of St. Jude Medical (NYSE:STJ) traded up 0.63% during mid-day trading on Thursday, hitting $60.50. The stock had a trading volume of 2,077,118 shares. St. Jude Medical has a 52 week low of $39.79 and a 52 week high of $68.39. The stock has a 50-day moving average of $62.99 and a 200-day moving average of $56.89. The company has a market cap of $17.920 billion and a price-to-earnings ratio of 24.16.
St. Jude Medical (NYSE:STJ) last announced its earnings results on Wednesday, January 22nd. The company reported $0.99 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.97 by $0.02. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. During the same quarter in the previous year, the company posted $0.90 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Analysts expect that St. Jude Medical will post $3.98 EPS for the current fiscal year.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.